PSP
AZN icon

Principal Street Partners’s AstraZeneca AZN Stock Holding History

Principal Street Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$971K Sell
4,923
-1
-0% -$193 0.16% 80
2025
Q4 		$905K Sell
4,924
-487
-9% -$85.4K 0.15% 81
2025
Q3 		$830K Sell
5,411
-10,141
-65% -$1.53M 0.13% 93
2025
Q2 		$2.17M Buy
15,552
+10,454
+205% +$1.47M 0.21% 72
2025
Q1 		$749K Buy
5,098
+641
+14% +$92.7K 0.14% 91
2024
Q4 		$584K Sell
4,457
-4,610
-51% -$645K 0.11% 114
2024
Q3 		$1.41M Buy
9,067
+4,493
+98% +$725K 0.23% 70
2024
Q2 		$713K Hold
4,574
– – 0.13% 93
2024
Q1 		$705K Buy
4,574
+223
+5% +$29.5K 0.13% 103
2023
Q4 		$586K Sell
4,351
-4,684
-52% -$609K 0.14% 101
2023
Q3 		$1.22M Buy
9,035
+4,644
+106% +$634K 0.24% 74
2023
Q2 		$629K Buy
4,391
+34
+0.8% +$5K 0.15% 97
2023
Q1 		$605K Sell
4,357
-159
-4% -$21.4K 0.15% 98
2022
Q4 		$612K Sell
4,516
-357
-7% -$44.8K 0.15% 99
2022
Q3 		$534K Sell
4,873
-136
-3% -$17.3K 0.14% 118
2022
Q2 		$662K Buy
5,009
+140
+3% +$18.4K 0.17% 94
2022
Q1 		$646K Buy
+4,869
New +$584K 0.15% 118
2021
Q4 		– Sell
-4,491
Closed -$539K – 196
2021
Q3 		$539K Buy
4,491
+1,322
+42% +$154K 0.15% 114
2021
Q2 		$380K Buy
3,169
+218
+7% +$23.9K 0.1% 149
2021
Q1 		$293K Buy
2,951
+23
+0.8% +$2.31K 0.04% 174
2020
Q4 		$293K Hold
2,928
– – 0.09% 148
2020
Q3 		$321K Buy
+2,928
New +$326K 0.11% 119
2020
Q2 		– Sell
-4,074
Closed -$364K – 129
2020
Q1 		$364K Hold
4,074
– – 0.15% 100
2019
Q4 		$406K Hold
4,074
– – 0.09% 147
2019
Q3 		$363K Buy
4,074
+18
+0.4% +$1.56K 0.09% 146
2019
Q2 		$335K Buy
+4,056
New +$318K 0.18% 118

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Principal Street Partners's AZN Position: Q1 2026 in Review

Principal Street Partners reduced its AstraZeneca (AZN) stake by 0.02% in Q1 2026, selling an estimated $193 and leaving 4,923 shares worth $971K. The position accounts for 0.16% of the portfolio, ranked #80.

Principal Street Partners first reported a position in AZN in Q2 2019 and has held it in 26 quarters since. The position peaked at $2.17M in Q2 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Principal Street Partners held 4,923 shares of AstraZeneca worth $971K as of Q1 2026.
  • Principal Street Partners sold 1 AstraZeneca share in Q1 2026, an estimated $193.
  • AstraZeneca made up 0.16% of Principal Street Partners's portfolio in Q1 2026, its #80 holding.
  • Principal Street Partners first reported a position in AstraZeneca in Q2 2019 and has held it in 26 quarters since.
  • Principal Street Partners's AstraZeneca position peaked at $2.17M in Q2 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.